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SUMMARY
Atherosclerosis, which underlies life-threatening cardiovascular disorders including myocardial 
infarction and stroke1, is initiated by low density lipoprotein cholesterol (LDL) passage into the 
artery wall and engulfment by macrophages, leading to foam cell formation and lesion 
development2, 2, 3, 3. How circulating LDL enters the artery wall to instigate atherosclerosis is 
unknown. Here we show in mice that scavenger receptor, class B type 1 (SR-B1) in endothelial 
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cells mediates LDL delivery into arteries and its accumulation by artery wall macrophages, 
thereby promoting atherosclerosis. LDL particles are colocalized with SR-B1 in endothelial cell 
intracellular vesicles in vivo, and LDL transcytosis across endothelial monolayers requires its 
direct binding to SR-B1 and an 8 amino acid cytoplasmic domain of the receptor that recruits the 
guanine nucleotide exchange factor dedicator of cytokinesis 4 (DOCK4)4. DOCK4 promotes SR-
B1 internalization and LDL transport by coupling LDL binding to SR-B1 with Rac1 activation. 
SR-B1 and DOCK4 expression are increased in atherosclerosis-prone regions of the mouse aorta 
prior to lesion formation, and in human atherosclerotic versus normal arteries. These findings 
challenge the long-held concept that atherogenesis involves passive LDL movement across a 
compromised endothelial barrier. Interventions inhibiting endothelial delivery of LDL into the 
artery wall may represent a new therapeutic category in the battle against cardiovascular disease.
In atherosclerosis, the balance of actions of lipoprotein particles governs the severity of the 
disorder and the likelihood that clinical cardiovascular events will occur. Whereas LDL that 
enters the artery wall is the critical driver of atherogenesis, via binding to SR-B1 in 
hepatocytes, high density lipoprotein particles (HDL) mediate reverse cholesterol transport 
(RCT) to the liver for biliary disposal and are thereby antiatherogenic5. In addition, in 
endothelial cells via SR-B1 and its adaptor PDZK1, HDL stimulates endothelial NO 
synthase (eNOS)6, endothelial repair and anti-inflammatory processes which may also be 
atheroprotective7. To determine how SR-B1 in endothelium impacts atherosclerosis, mice 
lacking the receptor selectively in endothelium were generated (SR-B1ΔEC, Extended Data 
Fig. 1a–i) and placed on apolipoprotein E null (apoE−/−) background. To our initial surprise, 
compared with SR-B1 floxed (SR-B1fl/fl) controls, SR-B1ΔEC had markedly less 
atherosclerosis. This was evident in both males and females, and in mice on mixed or 
C57BL/6 background (Fig. 1a–e, Extended Data Fig. 2a–e,h–l), and it was phenocopied in 
mice with genetically-induced or PCSK9-induced LDL receptor (LDLR) deficiency 
(Extended Data Fig. 3a–e, 4a–e), underscoring the robustness of the phenotype. In stark 
contrast, with selective silencing of SR-B1 in hepatocytes, atherosclerosis was more severe 
and early deaths occurred related to coronary artery occlusions and fibrotic myocardial 
lesions (Extended Data Fig. 4m–q), as observed in SR-B1−/−;apoE−/− mice8. In all models 
tested the endothelial deletion of SR-B1 which yielded atheroprotection did not alter 
circulating total cholesterol, triglyceride or HDL levels, or lipoprotein profile (Fig. 1f–i, 
Extended Data Figs. 2f–g,m–n, 3f–i, and 4f–i). Endothelial SR-B1 also did not impact 
inflammation-related gene expression in the aorta, or leukocyte-endothelial cell adhesion 
under basal or TNFα-induced proinflammatory conditions (Extended Data Fig. 5a–k). 
Importantly, endothelial loss of the SR-B1 adaptor protein PDZK1 (PDZK1ΔEC, Extended 
Data Fig. 1j–o) had no effect on lesion severity (Extended Data Fig. 2o–s). Thus, in marked 
contrast to its role in hepatocytes, in the absence of impact on circulating lipids or vascular 
inflammation and independent of processes governed by PDZK1, SR-B1 in endothelium 
promotes atherosclerosis.
Since SR-B1 is a receptor for both HDL and LDL9, and in cultured endothelial cells SR-B1 
promotes LDL transcytosis10, the hypothesis was then tested that endothelial SR-B1 
influences atherosclerosis by regulating LDL-related processes in the artery wall. DiI-
labeled human native LDL (nLDL) transfer into the aorta was visualized in vivo by confocal 
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fluorescence microscopy. Following IV injection, far less DiI-nLDL entered the aorta of SR-
B1ΔEC mice compared to SR-B1fl/fl controls (Fig. 1j–l). Since circulating oxidized LDL 
(oxLDL) may also contribute to atherogenesis11, 12, DiI-labeled human oxLDL transfer was 
also visualized, and it was similarly diminished in SR-B1ΔEC (Extended Data Fig. 6a–c, 
Videos S1 and S2). Decreased human LDL transfer into the aorta in SR-B1ΔEC was 
confirmed by quantification in aorta homogenates (Extended Data Fig. 3j–k, 4j–k, 6d–e,j–k), 
and mouse LDL and IDL/VLDL uptake was also decreased (Extended Data Fig. 3l–m). As 
such, the prior finding of less LDL accumulation in ex vivo perfused arteries from global 
SR-B1−/− mice10 was likely related to loss of the receptor in endothelium. In SR-B1ΔEC 
mice, Evans blue dye uptake in aorta was unaltered (Fig. 1m), and in mice with intact 
endothelial SR-B1, anti-SR-B1 blocking antibody treatment lowered aorta LDL 
incorporation (Extended Data Fig. 6f–g,l–m) and LDL and SR-B1 were colocalized in 
endothelial cell intracellular vesicles (Fig. 1n, Extended Data Fig. 7). Moreover, whereas 
FACS studies of CD45+, F4/80+ macrophages indicated no change in their number in the 
artery wall in SR-B1ΔEC, fewer macrophages contained administered LDL (Fig. 1o–p, 
Extended Data Fig. 5l, 6h–i). These collective observations indicate that endothelial SR-B1 
mediates the transcellular transport of LDL from the circulation into the artery wall and the 
formation of foam cells, thereby promoting atherosclerosis.
The relative importance and mechanistic basis for SR-BI trafficking of LDL was then 
explored in human aortic endothelial cells (HAEC). Regarding the initial step in LDL 
transport, whereas SR-B1 knockdown decreased Di-I LDL uptake, PDZK1 ablation had no 
effect (Extended Data Fig. 8a), as previously observed with HDL13. SR-B1 blocking 
antibody and the chemical SR-B1 inhibitor BLT-1 also attenuated LDL uptake, and either 
treatment or SR-B1 knockdown blunted LDL transcytosis across endothelial cell monolayers 
(Extended Data Fig. 8b–d). Whether the loss of SR-B1 impairs the function of endothelial 
cell caveolae, which mediate LDL transport14, 15, was assessed in studies of ligand-induced 
eNOS activation. Whereas SR-B1 silencing predictably negated HDL activation of eNOS6, 
stimulation by the eNOS agonist VEGF was unaffected (Extended Data Fig. 8e), paralleling 
complete loss versus no change in vasodilation with HDL versus acetylcholine in aortic 
rings from SR-B1−/− mice6. In contrast, cyclodextrin disruption of caveolae structure 
blunted eNOS activation by both VEGF and HDL (Extended Data Fig. 8f). Thus, the 
attenuation of LDL transport observed with the loss of SR-B1 from endothelial cells is not 
related to an alteration of the caveolae microenvironment.
The capacity of other endothelial receptors for LDL to mediate transport of the lipoprotein 
was also determined16–18. Whereas LOX-1 knockdown did not alter nLDL or oxLDL uptake 
by HAEC (data not shown), RNAi silencing of the LDL receptor (LDLR) or CD36 
attenuated uptake, and blocking antibodies had similar effect; however, neither LDLR nor 
CD36 antibody blockade impacted nLDL or oxLDL transcytosis (Extended Data Fig. 8g–
m). Thus, amongst classical lipoprotein receptors, whereas LDLR, CD36 and SR-B1 all 
promote LDL uptake by human endothelial cells, SR-B1 drives LDL transcytosis.
We next compared the capacity for endothelial LDL transcytosis by SR-B1 and activing 
receptor-like kinase 1 (ALK1), to which LDL binding and transport has been previously 
ascribed19. LDL transcytosis was decreased to a similar degree by the selective loss of SR-
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B1 or ALK1, and there was a further decline with their concurrent knockdown (Extended 
Data Fig. 9a–f). Thus, both SR-B1 and ALK1 mediate LDL transcytosis in endothelial cells, 
and they likely do so by different mechanisms. Importantly, endothelial ALK1 expression 
was normal in SR-B1ΔEC mice (Extended Data Fig. 1f), such that the in vivo findings for 
endothelial SR-B1 and artery LDL delivery, macrophage LDL uptake and atherosclerosis 
can be attributed specifically to SR-B1.
We then determined if LDL binding to SR-B1 is required for LDL trafficking across 
endothelium. Endogenous SR-B1 was silenced in HAEC, and expression was reconstituted 
with wild-type SR-BI or 5 point mutant forms previously (M159E and T165E)20 or newly 
identified (F171A, T175A, and E178A) to have attenuated LDL binding (Fig. 2a, Extended 
Data Fig. 10a–c). Another point mutant, Q445A, with normal LDL binding (Extended Data 
Fig. 10c) but disrupted SR-B1 interaction with plasma membrane cholesterol21 was also 
tested. Whereas reintroduction of wild-type SR-B1 yielded nLDL and oxLDL uptake 
comparable to that for endogenous SR-B1, cells expressing SR-B1 with decreased LDL 
binding had markedly diminished LDL uptake; in contrast, cells harboring the Q445A 
mutant displayed normal LDL uptake (Fig. 2b). The vast majority of LDL transcytosis by 
SR-B1 was also attenuated if LDL binding was diminished (Fig. 2c). Thus, direct 
association is essential to LDL trafficking by SR-B1 in endothelial cells.
Since SR-B1 lacks the internalization sequence Tyr-X-X-θ (X is any amino acid and θ is a 
bulky hydrophobic amino acid) characteristic of other LDL receptors22, we raised the 
hypothesis that SR-B1 has an associated partner protein(s) required for its internalization 
and endothelial LDL transcytosis. As a first test, we generated deletion mutants lacking the 
C-terminal 15, 23 or 30 residues of SR-B1, designated ΔC15 (Δ495–509), ΔC23 (Δ487–509) 
and ΔC30 (Δ480–509) (Fig. 2a, Extended Data Fig. 10d–f). Whereas cells expressing ΔC15 
had LDL uptake and transcytosis comparable to cells expressing full-length wild-type SR-
B1, both processes were attenuated in cells harboring ΔC23 or ΔC30 (Fig. 2d,e). These 
findings suggested that residues 487–494 (IQAYSESL; Fig. 2a), which are highly conserved 
in SR-B1 and unique to SR-B1 versus CD36 (Extended Data Fig. 10g), are required. To test 
this possibility, alanines were substituted for the first four (IQAY) or last four (SESL) 
residues, or single alanine substitutions were generated (Fig. 2a, Extended Data Fig. 10h–j). 
Cells expressing the IQAY or SESL mutant or Y490A or S491A displayed dramatically 
reduced nLDL and oxLDL uptake and transcytosis (Fig. 2f,g); Q488A had attenuated nLDL 
uptake and transcytosis. Testing various receptor mutants, the findings for binding, uptake 
and transcytosis were confirmed at nLDL concentrations that saturate LDLR binding 
(100ug/ml), and endogenous CD36 and LDLR abundance was shown to be unaltered 
(Extended Data Fig. 10k–n). As such, amino acids 487 to 494 in the C-terminal cytoplasmic 
tail of SR-B1, IQAYSESL, are critical for LDL uptake and transcytosis by endothelial cells.
Next we tested the hypothesis that residues 487 to 494 of SR-B1 are required for receptor 
interaction with a cytoplasmic protein(s) necessary for LDL transport. The interactomes of 
N-terminally-HIS-tagged SR-B1 or SR-B1-ΔC23 in HAEC were evaluated by liquid 
chromatography/tandem mass spectrometry. One of the 33 proteins demonstrating greater 
interaction with HIS-SR-B1 versus HIS-SR-B1-ΔC23 was dedicator of cytokinesis 4 
(DOCK4), which is a membrane-associated cytoplasmic protein that functions as a guanine 
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nucleotide exchange factor (GEF) and a participant in actin cytoskeleton regulation4, 23, 24. 
Coimmunoprecipitation experiments in HAEC confirmed DOCK4 interaction with amino 
acids 487 to 494 of SR-B1 (Fig. 3a–b), and nLDL and oxLDL caused similar 72 to 94% 
increases in SR-B1-DOCK4 coupling (Fig. 3c). In vivo coexpression of SR-B1 and DOCK4 
was demonstrated in aortic endothelium (Fig. 3d), and compared to the atherosclerosis-
resistant greater curvature of the aortic arch, both SR-B1 and DOCK4 mRNA levels were 
increased in the atherosclerosis-prone lesser curvature prior to lesion formation (Fig. 3e–f). 
Furthermore, in three independent, publicly-available patient cohorts (Fig. 3g–l) both SR-B1 
and DOCK4 expression was greater in atherosclerotic arteries versus normal arteries (Fig. 
3g–l).
Since DOCK4 mediates PDGF receptor internalization in fibroblasts24, whether SR-B1 is 
internalized in endothelial cells, and if so, whether DOCK4 is required was then interrogated 
in HAEC. Upon the resumption of endocytosis with warming from 4°C to 37°C in the 
presence of nLDL or oxLDL, the internalization of cell surface biotin-labeled SR-B1 was 
demonstrable in cells expressing DOCK4, and DOCK4 knockdown attenuated the 
internalization (Fig. 4a,b). In contrast, transferrin receptor internalization was not affected 
by DOCK4 deletion, revealing that DOCK4 does not influence endothelial cell SR-B1 
endocytosis nonspecifically. It was further found that DOCK4 impacts the degree of LDL 
binding to SR-B1 but not to LDLR or CD36 (Fig. 4c,d). Importantly, silencing of DOCK4 
suppressed SR-B1-dependent LDL uptake and transcytosis assessed using either DiI-labeled 
or 125I-labeled LDL (Fig. 4e,f, Extended Data Fig. 9g–j), and requirements for both SR-B1 
and DOCK4 in LDL transcytosis were confirmed using total internal reflection fluorescence 
(TIRF) microscopy (Extended Data Fig. 9k–l). In contrast, whereas HDL transcytosis was 
decreased by SR-B1 silencing as previously shown13, DOCK4 knockdown had no effect 
(Fig. 4g), indicating cargo-specific participation of DOCK4 in SR-B1 transport of 
lipoproteins in endothelial cells. Since DOCK4 is a GEF for Rac14, Rac1 participation in 
LDL trafficking was evaluated. Treatment with LDL caused Rac1 activation, the activation 
was prevented by silencing either SR-B1 or DOCK4 (Fig. 4h,i), and attenuation of the 
activation (FExtended Data Fig. 9m) blunted LDL uptake by SR-B1 (Figure 4j). Thus, 
through a dynamic partnership with DOCK4 serving as a GEF for Rac1, SR-B1 mediates 
endothelial cell LDL transcytosis to deliver circulating LDL into the subendothelial space to 
be engulfed by macrophages that become foam cells and promote atherosclerotic lesion 
formation (Fig. 4k).
It has long been believed that the delivery of circulating LDL into the artery wall that 
instigates atherosclerosis entails its passive movement through a compromised endothelial 
barrier at lesion-prone sites, which display higher rates of endothelial senescence and 
apoptosis, and reduced proliferative reserve and repair capacity25–27. We now reveal that 
active transcellular LDL transport by SR-B1 in the endothelium drives atherogenesis. With 
mechanistic understanding of disease-promoting artery wall LDL entry now in hand, 
interventions inhibiting the process may represent a new therapeutic category in the battle 
against cardiovascular disease.
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METHODS
Animal Models
Experiments were performed in male and female wild-type, apoE−/−, LDLR−/−, SR-B1fl/fl, 
PDZK1fl/fl, VECad-Cre and Alb-Cre mice, or in offspring from their mating. The targeting 
construct to create floxed SR-B1 mice (SR-B1fl/fl) contained loxP sites inserted in intron 1 
and intron 3 of the Scarb1 gene. The heterozygous SR-B1fl/+ mice initially created on mixed 
background were crossed with apoE−/− and VECad-Cre mice to generate 
hypercholesterolemic littermates expressing versus deficient in SR-B1 in endothelium (apoE
−/−;SR-B1fl/fl versus apoE−/−;SR-B1fl/fl;VECad-Cre designated apoE−/−;SR-B1ΔEC), and 
these were employed in the initial studies of atherosclerosis. The heterozygous SR-B1fl/+ 
mice were also backcrossed to C57BL/6 for more than eight generations, with resulting mice 
on C57BL/6 background used in experiments that followed. With additional matings LDLR
−/−;SR-B1fl/fl versus LDLR−/−;SR-B1fl/fl;VECad-Cre designated LDLR−/−;SR-B1ΔEC were 
also produced. The present use of SR-B1ΔEC for receptor loss-of-function in endothelium 
contrasts with previous gain-of-function studies performed in mice harboring a Tie2-driven 
SR-B1 transgene28. In that work SR-B1 overexpression yielded atheroprotection. However, 
the transgene caused a decline in plasma cholesterol and a 50% increase in HDL, and since 
Tie2-driven gene expression occurs in hematopoietic lineages and endothelium29, non-
endothelial processes cannot be excluded. We also crossed SR-B1ΔEC with Alb-Cre mice 
(B6.Cg-Tg(Alb-Cre)21Mgn/J, Jackson Laboratory)30 to generate mice deficient in SR-B1 in 
hepatocytes, designated SR-B1ΔHEP. The targeting construct to create floxed PDZK1 mice 
(PDZK1fl/fl), which contained lox P sites inserted in intron 1 and intron 4, was created by 
BAC recombineering31. BAC RP23–405I24 containing the mouse PDZK1 gene was kindly 
provided by the Children’s Hospital Oakland Research Institute (CHORI). The heterozygous 
PDZK1fl/+ mice initially produced were backcrossed to C57BL/6 for more than eight 
generations before crossing with apoE−/− and VECad-Cre for studies of endothelial PDZK1 
in apoE−/−;PDZK1fl/fl versus apoE−/−;PDZK1fl/fl;VECad-Cre mice, designated apoE
−/−;PDZK1ΔEC. The cell specificity of SR-B1 or PDZK1 knockdown was evaluated by 
quantitative RT-PCR or immunoblotting in primary aortic endothelial cells32 versus myeloid 
lineage cells purified from bone marrow using anti-CD11b and anti-Gr-1 antibodies (BD 
Biosciences). Effective excision of the genes in endothelium was also demonstrated by PCR-
based genotyping on aortas with versus without intact endothelium. In select experiments 
LDLR was downregulated in the liver by an IV injection of AAV8-PCSK9 (5×1011gc/
mouse). All mice were maintained on standard chow. In studies of atherosclerosis, beginning 
at weaning at age 4 weeks apoE−/−mice received an atherogenetic diet (D12108C, 20% fat, 
1.25% cholesterol, Research Diets Inc.) for 8 weeks, LDLR−/− were fed TD96335 (6.2% fat, 
1.25% cholesterol, Harlan Laboratories) for 12 weeks, or following AAV8-PCSK9 injection 
at 4–5 weeks of age, mice received TD96335 for up to 12 weeks. All animal experiments 
were approved by the Institutional Animal Care and Use Committee at UT Southwestern.
Atherosclerosis Evaluation and Lipid Analyses
Atherosclerotic lesions were evaluated as previously described33. Mice were anesthetized 
with isoflurane, blood was collected for lipid analyses, and the vascular system was perfused 
with normal saline administered by left ventricle puncture. Adventitial fat was removed from 
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the aortic arch prior to in situ imaging. The heart and whole aorta were isolated and placed 
in 10% formalin for fixation overnight, the heart was dehydrated in 30% sucrose at 4°C 
overnight and embedded in OCT compound (Fisher Healthcare), and serial frozen sections 
(8um) of the aortic root were obtained. Ten to fifteen slides with 6 sequential sections each 
were prepared from each heart, and 1–2 slides per heart were processed for Oil Red O 
staining of the aortic sinus. For en face analysis, the entire aorta from the aorta root through 
the bifurcation of the iliac arteries was stained with Oil Red O for 2h at room temperature, 
adjoining tissues were removed, and the aorta was opened longitudinally and pinned onto a 
black silicon bed. Lesion quantification was evaluated by morphometry of obtained images 
using Photoshop software.
Plasma total cholesterol and triglyceride concentrations were determined by colorimetric 
enzymatic assay (Infinity, Thermo Scientific). HDL levels were determined by precipitating 
apoB-containing lipoproteins using phosphotungstate-magnesium and measurement using 
the HDL Cholesterol Kit (Wako)34. Plasma lipid profiles were obtained by column 
fractionation and measurements of fraction cholesterol content35.
Cardiac Phenotyping
Using previously-described methods8, hearts were excised and rinsed in PBS and fixed in 
10% formalin for 48h, embedded in paraffin, and sectioned at 5um intervals. Hematoxylin 
and eosin staining and Masson’s trichrome staining were performed following standard 
procedures. Macrophage content was evaluated by immunohistochemistry using anti-CD68 
antibody (ab955, Abcam). Survival curves were generated to compare the overall outcome 
of SR-B1fl/fl controls and SR-B1ΔHEP that were made hypercholesterolemic with AAV8-
PCSK9.
In Vivo Leukocyte-endothelial Adhesion and Endothelial Permeability
Leukocyte-endothelial adhesion was assessed using our previously-established method35. 
Briefly, in 4- to 5-week-old male mice, endogenous leukocytes were fluorescence labeled by 
injection with 100ul Rhodamine-6G (0.05% w/v) via optic vascular plexus. Under 
anesthesia the mesentery was exposed on a clear dish for the observation and recording of 
images of leukocyte adhesion and rolling in the mesenteric microvasculature using a Regita 
digital camera (400x magnification; QImaging). The velocity of leukocyte rolling was 
calculated using Image-Pro V.6.2 (Media Cybernetics). To evaluate adhesion under both 
control and pro-inflammatory conditions, mice received an IP injection of normal saline or 
TNFα (0.3ug/mouse) 4h prior to study.
To evaluate endothelial permeability, mice were injected retro-orbitally with 0.5% (w/v) 
Evans blue dye dissolved in normal saline (4ul/g body weight) as described previously36. 
After 1h, the mice were euthanized and perfused via the left ventricle with 10ml cold PBS. 
The entire aorta was isolated, washed in PBS, and placed in formamide at 55°C for 48h. 
Following centrifugation the dye concentration was determined by measuring absorbance at 
650nm with comparison to a standard curve.
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In Vivo Aorta LDL Uptake
Human native LDL (nLDL) was kindly provided by Drs. J. Goldstein and M. Brown (UT 
Southwestern). Briefly, LDL particles were isolated by ultracentrifugation from normal 
human plasma and stored in buffer containing 0.27mM EDTA at 4°C. To generate oxidized 
LDL (oxLDL), nLDL particles at a concentration of 1 mg protein/ml were incubated with 
5uM CuSO4 at 37°C for 24h, 100uM EDTA and 20uM butylated hydroxytoluene were 
added to terminate oxidation, and the resulting samples were dialyzed with PBS for 48h. 
Murine LDL (density 1.019–1.063 g/ml) and VLDL/IDL (density 1.006–1.019 g/ml) was 
obtained from pooled LDLR−/− mouse plasma by sequential ultracentrigation37. To optimize 
their detection, nLDL, oxLDL or murine LDL or VLDL/IDL were labeled with 
1,1’dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate (Dil, Invitrogen) at 37°C 
for 16h, centrifuged at 16,000 × g for 10min at 4°C, and dialyzed with PBS for 24h. Dil-
labeled LDLs were stored at 4°C and used within 1–2 weeks38.
To evaluate aorta LDL uptake in vivo, following receipt of an atherogenic diet for one week, 
8–10 week-old mice were injected retro-orbitally with 100ug Dil-LDL, and 0 to 4h later the 
mice were anesthetized and perfused with ice-cold PBS for 5min, and the thoracic aorta was 
isolated. Following removal of the adventitia, the aorta was digested in RIPA buffer (Thermo 
Fisher) containing protease inhibitor cocktail (P8340, Sigma), and DiI-labeled lipoprotein 
content was quantified either using a fluorometer (POLARstar Omega, BMG LABTECH) 
and measurement of aorta homogenate protein content (Pierce BCA Protein Assay Kit), or 
when human LDL was employed, by immunoblotting with anti-human apoB antibody 
(MA5–15851, ThermoFisher) and anti-calnexin antibody (ADI-SPA-860-F, Enzo Life 
Sciences) to assess protein loading. To test the impact of a pharmacologic intervention 
targeting SR-B1, in select experiments the mice received either control sera or SR-B1 
blocking antibody (1:2 dilution, 200ul)39 both16h and 1h prior to the administration of DiI-
LDL.
To visualize LDL transport across the endothelial monolayer in vivo, 4h following 
intravenous DiI-LDL administration the aorta was isolated, subjected to Hoechst staining 
(5ug/ml) at 4°C for 30min to identify nuclei, washed X3, and then fluorescence confocal 
microscopy was performed on the luminal surface using a 20X objective and a Zeiss 
LSM710 NLO two-photon excitation microscope. The methods were adapted from 
approaches employed to image the brain vasculature of mice40. A minimum of three 
randomly-selected regions in the ascending aorta were imaged per mouse to a depth of 
approximately 50μm (Z=1–2μm), and the data obtained were analyzed by Zeiss ZEN 
software.
To quantify LDL uptake by arterial wall macrophages/foam cells, 4h following intravenous 
DiI-LDL administration, CD45+, F4/80+ cells were isolated from the aorta using our 
established approach41. The aorta was digested with liberase TH (4 U/ml, Roche), 
deoxyribonuclease (DNase) I (0.1 mg/ml, Sigma), and hyaluronidase (60 U/ml, Sigma) at 
37°C for 2h, and flow cytometry (BD Biosciences LSR II) was performed with 1:200 
dilutions of anti-CD45 (clone 30-F11) and anti-F4/80 (clone BM8) antibodies obtained from 
Biolegend as well as detection of Di-I signal. Data obtained were analyzed using FlowJo 
software (Treestar).
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Electron Microscopy
The subcellular localization of intravascularly-administered LDL particles and SR-B1 in 
aortic endothelial cells was evaluated by electron microscopy (EM). Following fasting for 
4h, 10 week-old C57BL/6 mice were anesthetized and the aorta was cleared of blood in situ 
by perfusion with PBS with 0.25% glucose at 37°C. The thoracic aorta was then perfused 
(15ml/min) with colloidal gold-labeled nLDL (10–15nm diameter, 50ug/ml in EBM2 
medium plus 1%BSA, 37°C)42, 43 from proximal to distal, and the perfusate was 
recirculated. Ten minutes later the thoracic aorta was washed with ice-cold PBS (10 ml) to 
remove unbound LDL, harvested and opened longitudinally, and incubated in EM fixation 
solution (4% PFA in 0.1M phosphate buffer pH7.4, containing 0.1% glutaraldehyde) for 
30min at room temperature. SR-B1 was visualized using a primary antibody to mouse SR-
B1 (Novus, NB400–104)44 and a fluoronanogold (1.4nm diameter)-conjugated secondary 
antibody (Alexa Fluor 488-FluoroNanogold Fab’ goat anti-rabbit IgG, 7204, Nanoprobes). 
The immunogold-labeled samples were further gold-enhanced for 2.5 min using a gold 
enhancement kit (Nanoprobes). After washing with water and 0.1M cacodylate buffer, 
samples were fixed with 1% OsO4 and 0.8% potassium ferricyanide in 0.1M cacodylate 
buffer for 1h, stained en bloc with 2% aquaous uranyl acetate, dehydrated with increasing 
concentration of ethanol, and embedded in Epon. Blocks were sectioned with a diamond 
knife (Diatome) on a Leica Ultracut 7 ultramicrotome (Leica Microsystems) and collected 
onto copper grids. Images were acquired on a JOEL 1400 Plus transmission electron 
microscope equipped with a LaB6 source using a voltage of 120 kV, and the images were 
captured by an AMT BIOSPRINT 16M-ActiveVu mid mound CCD camera. In sections 
processed in the absence of primary anti-SR-B1 antibody, the gold particles detecting SR-B1 
were absent.
Cultured Cell Models, Gene Silencing and Reconstitution
Primary human aortic endothelial cells (HAEC) obtained from Lonza were maintained in 
EBM2 medium with 10% (v/v) fetal bovine serum and studied at passage 3 to 6. Gene 
silencing was accomplished using predesigned and validated siRNAs targeting SR-B1 
(s2648), PDZK1 (s10282), LOX1 (s9842), LDLR (S224006), or CD36 (s534752) (Life 
Technologies Corp.), and effective knockdown was confirmed by immunoblot analysis. 
ALK1 was silenced using shRNA (TRCN0000000354) (Sigma), and successful loss of 
ALK1 was confirmed by quantitative RT-PCR and measurement of SMAD1/5 Ser463/465 
phosphorylation in response to BMP9 treatment (10ng/ml) for 0 to 120 min19. In studies of 
DOCK4, gene silencing was done with a lentiviral shuttle plasmid for shRNA targeting 
human DOCK4 (TRCN0000288692) (Sigma). In select studies including the experiments 
determining the SR-B1 structural features required for LDL transport, the endogenous 
receptor was knocked down by shRNA targeting the 3’UTR of the human SR-B1 gene (5’- 
CCGGGCTCGTCAACAAGCACTGTTCCTCGAGGAACAGTGCTTGTTGACGAGCTTT
TTG-3’ in pLKO.1-TRC). Wild-type or mutant forms of SR-B1 were reintroduced using 
CMV promoter-driven lentiviral constructs. Polybrene (8ug/ml, EMD Millipore) was added 
to the medium to enhance lentiviral transduction efficiency, and experiments were performed 
48h later. The SR-B1 mutants were generated using cDNA encoding human Scarb1 
(NM_005505, Sino Biological Inc.) and the Virapower Lentiviral Expression System 
(ThermoFisher). Shuttle plasmid (5ug), psPAX2 packaging plasmid (3ug), and pMD2.G 
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envelope plasmid (2ug) were co-transfected into HEK-293FT cells in DMEM using 
Fugene6. Six hours and 48h post-transfection, the medium was replaced with DMEM 
containing 2mM caffeine and 30% FBS. The lentiviral particles were harvested 48h and 72h 
after transfection, passed through a 0.45um filter (Millipore) to remove cellular debris, 
concentrated by ultracentrifugation at 100,000 × g for 90min at 4°C, and resuspended in 
Dubelcco’s phosphate-buffered saline (Gibco) overnight at 4°C. The lentiviral preparations 
were then aliquotted and stored at −80°C, and SR-B1 mutations were confirmed by 
sequencing.
Total cell abundance of the reconstituted wild-type or mutant forms of SR-B1 was evaluated 
by immunoblot analysis 48h following lentiviral transduction. To assess their cell surface 
abundance, cells were incubated with anti-SR-B1 antibody directed against the extracellular 
domain (NB400–134, Novus Biologicals) on ice for 30min, washed X3, incubated with 
alexa488-conjugated secondary antibody for 30min at 4°C, washed X3, and subjected to 
flow cytometry (BD Biosciences LSR II).
Quantitative RT-PCR
Transcript abundance was evaluated in mouse aorta, mouse aortic endothelial cells or human 
endothelial cells by quantitative RT-PCR using previously established methods35.
LDL Binding, Uptake and Transcytosis
To evaluate DiI-LDL binding, cells in 24-well plates were precooled at 4°C for 10min, 
incubated with 50 ug/ml DiI-LDL at 4°C for 10 min, washed X3 with ice-cold PBS and 
lysed in 1% Triton X100 at room temperature for 10min with shaking, and fluorescence was 
quantified using a fluorometer (POLARstar Omega, BMG LABTECH) and normalized to 
total protein content.
LDL uptake studies entailed cell incubation with 10ug/ml DiI-LDL for 4h at 37°C. In select 
experiments the DiI-LDL incubation followed a 1h preincubation with DMSO control 
vehicle versus the SR-B1 inhibitor BLT-1 (10uM, Sigma)45, or control unrelated IgG versus 
anti-SR-B1 blocking antibody. DMSO control had no effect on LDL transport. Cells were 
washed with PBS and lysed for the measurement of fluorescence intensity by fluorometer. 
For imaging of LDL uptake, experiments were performed with cells seeded onto glass 
coverslips precoated with collagen I. Following DiI-LDL incubations the cells were fixed 
with 1% formalin in PBS for 10min at room temperature, nuclei were stained with DAPI, 
mounting media was added (Vector Laboratories, Inc.), and fluorescence microscopy was 
performed at 40X magnification with a Nikon Eclipse TE2000-E microscope.
LDL transcytosis was studied using approaches derived from previously-reported 
methods32. Cells were seeded twice, 24h apart, onto 0.4um pore PET Transwell inserts 
(3610, Corning, Inc.) coated with collagen I (BD Bioscience), with or without lentiviral 
transduction overnight. Transcytosis was evaluated 48h later, at which time measurements of 
transepithelial electrical resistance using an epithelial volt-ohmmeter (World Precision 
Instruments) confirmed the establishment of a confluent monolayer. FITC-dextran (M.W. 
3000; Invitrogen) was used to assess paracellular transport. Cells were incubated 
simultaneously for 2h with FITC-dextran and 50ug/ml Dil-LDL added to the upper chamber, 
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and the fluorescence intensity of FITC and Dil in the lower chamber was measured using a 
fluorometer (POLARstar Omega, BMG LABTECH). FITC-dextran transport was 2 to 3% 
and similar for control cells and cells in which SR-B1 expression was reconstituted. 
Infrequently-observed inserts displaying paracellular transport more than 5% were 
discarded. The addition of 50-fold excess LDL decreased the DiI signal for transcytosis by 
75%. In select experiments interventions were placed in the upper chamber for 1h prior to 
the addition of DiI-LDL. Under control conditions the percent transcytosis of DiI-LDL was 
approximately 12%, and the data shown are normalized to control values. HDL transcytosis 
was also performed using DiI-labeled lipoprotein. The validity of the uptake and transcytosis 
assays employing DiI-LDL was confirmed using nLDL labeled with iodine-125 by the 
Bolton-Hunter method. In uptake studies, cells were incubated with 10ug/ml 125I-LDL for 
4h, washed with PBS and lysed with 0.1N NaOH, and radioactivity was quantified in the 
cell lysate using a Wizard Automatic Gamma Counter (PerkinElmer) and expressed relative 
to protein content. For transcytosis studies, cells were incubated with 50ug/ml 125I-LDL for 
2h and radioactivity in both the upper and lower chambers was quantified.
To provide an additional means to confirm the findings obtained for transcytosis, total 
internal reflection fluorescence (TIRF) microscopy was employed10, 19. Time-lapse imaging 
of transcytosis was carried out on an OMX SR microscope in Ring TIRF mode (GE 
Healthcare Life Science). Briefly, endothelial cells seeded in 35 mm glass bottom dishes 
(MatTek, MA) were treated with 50μg/ml Dil-nLDL in EGM2 medium with HEPES at 4°C 
for 10 min to allow the LDL to bind to the apical cell surface without internalization. 
Endothelial cells pretreated with Dyngo4A (30μM; Abcam) for 30 min were processed in 
parallel to confirm dynamin dependence of transcytotic events10. The cells were rinsed with 
cold PBS, and warm medium was added, and the dish was placed in a 37°C live cell 
incubation chamber on the microscope stage for 2 min before imaging. An Olympus ApoN 
60× 1.49 NA lens was used for through the objective TIRF with 561 nm laser excitation. The 
TIRF angle was set at 96% of the back aperture of the lens, for an estimated nominal 
penetration depth of 70 nm. Images were acquired using a cooled sCMOS camera with a 50 
ms exposure at 150 ms intervals for a minimum of 40 sec. At least 15 randomly-selected 
cells were imaged for each condition, and the transcytosis events in the first 5 to 6 cells 
imaged were quantified using Imaris 9.2.0. image analysis software (Bitplane, Zurich 
Switzerland). The Spots Wizard was used to identify DiI-labeled LDL particles and track 
them over time. The spots were filtered based on mean squared displacement over time to 
exclude those exhibiting Brownian motion or active transport, and statistics measured by 
Imaris were exported for analysis in Excel. Numbers of transcytosis events captured in 200 
frames were determined using criteria reported previously19.
NOS Assays
To assess caveolae function in cultured endothelial cells, the conversion of 14C-L-arginine to 
14C-L-citrulline was measured in intact cells under basal conditions or with the addition of 
VEGF (100ng/ml) or HDL (20ug/ml)46. In select studies caveolae were disrupted by cell 
treatment with methyl-β-cyclodextrin (10mM for 60min) prior to the evaluation of NOS 
activation.
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Liquid Chromatography/Tandem Mass Spectrometry (LC/MS-MS)
To identify proteins that interact with SR-B1 in endothelial cells, SR-B1 
immunoprecipitation was facilitated by N-terminal HIS tagging of the receptor. N-terminal 
tagging was chosen because the SR-B1 N-terminal tail does not participate in any known 
function of the receptor47, and the addition of the N-terminal HIS tag did not affect LDL 
uptake by SR-B1 in HAEC (data not shown). An N-terminal HIS tag was also placed on the 
SR-B1-ΔC23 truncated form of the receptor. Endogenous SR-B1 was silenced in HAEC, 
receptor expression was reconstituted with either HIS-SR-B1 or HIS-SR-B1-ΔC23, SR-B1 
was immunoprecipitated with anti-HIS antibody, and the associated proteins were evaluated 
by liquid chromatography/tandem mass spectrometry (LC/MS-MS). Immunoprecipitated 
protein samples were electroporated 10mm into the top of a pre-cast SDS-PAGE gel (Bio-
Rad), stained with Coomassie blue and excised. Following alkylation and reduction with 
dithiothreitol and iodoacetamide (Sigma), samples were digested overnight with trypsin 
(Promega) and then subjected to LC/MS-MS using a QExactive mass spectrometer (Thermo 
Electron) coupled to an Ultimate 3000 RSLC-Nano liquid chromatography system (Dionex). 
Peptides were loaded onto a 180μm i.d., 5cm long, self-packed column containing 1.9μm 
C18 resin (Dr. Maisch, Ammerbuch, Germany) and eluted with a gradient of 0–40% buffer 
containing 80% (vol/vol) ACN, 10% (vol/vol) trifluoroethanol, and 0.08% formic acid for 60 
min. Up to 10 high-energy, collision-induced dissociation fragment spectra were obtained 
for each full spectrum acquired. Raw MS data files were converted to peak list format using 
ProteoWizard Msconvert, and the resulting files were analyzed using the Central Proteomics 
Facilities Pipeline48. Label-free quantitation of proteins across samples was performed using 
the Normalized Spectral Index method (SINQ)49.
Co-immunoprecipitation and Immunoblot Analyses
Co-immunoprecipitation studies were performed to evaluate proteins interacting with either 
HIS-tagged wild-type or mutant SR-B1, or DOCK4 in HAEC. Cells were incubated with 
lysis buffer containing 25mM Tris-HCl, pH7.4, 150mM NaCl, 1% NP-40, 1mM EDTA, and 
5% glycerol (Thermo Fisher) supplemented with protease inhibitor cocktail (P8340, Sigma) 
on ice for 1h with vortexing every 20min. Supernatants collected following centrifugation at 
14,000 × g at 4°C for 10 min were incubated with control IgG, anti-DOCK4 (ab85723, 
Abcam) or anti-HIS tag (ab18184, Abcam) antibody at 4°C overnight, and protein A/G plus 
agarose beads (Pierce) were added for 2h. The beads were pelleted by centrifugation, 
washed X3, and the bound proteins were eluted with SDS sample buffer and analyzed by 
SDS-PAGE and immunoblotting. Primary antibodies employed were anti-DOCK4 antibody, 
and anti-SR-B1 antibody recognizing the N-terminus (ab52629, Abcam) to identify C-
terminally-truncated SR-B1. HRP-conjugated secondary antibodies and chemiluminescent 
detection and densitometry were then employed.
In cell culture experiments additional immunoblot analyses were performed employing anti-
SR-B1 (NB400–113 and NB400–134,Novus; ab52629, Abcam), anti- PDZK1 (ab64856, 
Abcam), anti-LOX-1(MAB1798, R&D Systems), anti-LDLR (AF2148, R&D Systems), 
anti-CD36 (NB400–144,Novus; MA-5–14112, Invitrogen) and anti-transferrin receptor 
(ab84036, Abcam) antibodies. Protein loading was assessed using anti-GAPDH (sc-365062, 
Santa Cruz) antibody.
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Gene Expression Profiling in Human Atherosclerotic versus Normal Arteries
To compare SR-B1 and DOCK4 in human atherosclerotic versus normal arteries, three 
publicly available independent human atherosclerosis cohorts with gene expression data 
were downloaded from Gene Expression Omnibus (GEO, https://www.ncbi.nlm.nih.gov/
geo/). The accession numbers were GSE116243, GSE40231, and GSE43292. For the 
GSE116243 cohort (Cohort I), which included atherosclerotic aortic lesions, the gene 
expression profiling was generated by RNA sequencing through Illumina HiSeq 2500. For 
comparison, RNA sequencing datasets of aorta from healthy donors were downloaded from 
Genotype-Tissue Expression (GTEx) database with accession number phs000424.v6.p1. 
RNA-seq reads from FASTQ files were quality-filtered using FASTQ Quality Filter (-q 20 –
p 75) from FASTX-toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). The filtered reads were 
then aligned to hg38 reference genome by HISAT2 aligner50. Cufflinks51 was used to 
assemble and estimate the relative abundances of transcripts at the gene and transcript level. 
For the GSE40231 cohort (Cohort II), which compared atherosclerotic aortic lesions with 
internal mammary artery from the same subjects, gene expression profiling was generated by 
Affymetrix Human Genome U133 Plus 2.0 Array. Signal intensity CEL files were 
downloaded from GEO and then processed by Affymetrix Power Tools (APT) with Robust 
Multiarray Average (RMA) method. For the GSE43292 cohort (Cohort III), which matched 
atherosclerotic carotid artery with healthy carotid artery from the same subject, gene 
expression profiling was generated by Affymetrix Human Gene 1.0 ST Array. CELL files 
were downloaded from GEO and then were analyzed using R/BioConductor package with 
RMA method and custom PERL scripts. Data are presented as box-and-whisker plots, with 
the central lines denoting medians, edges of the box representing upper and lower quartiles, 
and whiskers showing minimum and maximum values after excluding outliers outside 1.5 
times the interquartile range. Notably although the analyses of the three cohorts utilized 
distinct technology platforms to measure gene expression, the same findings were obtained.
SR-B1 Internalization
To evaluate SR-B1 internalization, following surface protein labeling with 2mM Sulfo-NHS-
SS-biotin at 4°C for 30min33, the cells were washed with 100mM glycine in PBS to quench 
non-reacted biotinylation reagent, and then incubated with 50 ug/ml Dil-LDL at 37°C for 0 
to 10min. Remaining cell surface biotin was cleaved with 50mM reduced glutathione 
(Sigma), cells were lysed in RIPA buffer, biotinylated proteins were isolated by incubating 
with streptavidin magnetic beads overnight at 4°C, the bound proteins were eluted with 
loading buffer, and immunoblot analysis was performed. To assess the efficacy of SR-B1 
biotinylation, whole cell lysates were obtained at 0 to 10min of incubation, and total 
biotinylated SR-B1 was quantified by immunoblotting. To evaluate the internalization of 
another cell surface protein, the abundance of internalized transferrin receptor and total 
biotinylated transferrin receptor was determined in a parallel manner.
Rac1 Activity Assay and Rac1 Loss-of-function
Rac1 activity was evaluated by affinity purification and immunoblotting (Millipore). 
Following cell treatment, cell lysates were incubated with PAK1 PBD agarose to bind 
activated, GTP-bound Rac1, and its abundance was determined by immunoblotting. Total 
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Rac1 in cell lysates was also evaluated by immunoblotting. To determine the role of Rac1 in 
endothelial cell LDL uptake, cells were transduced with adenovirus encoding GFP or a 
dominant-negative form of Rac1 (T17N)52 with MOI 100 for 48h prior to the uptake assay. 
The impact of pharmacologic inhibition was also tested, pretreating cells with vehicle or the 
Rac1 inhibitor NSC23766 (100uM)53 for 1h prior to the uptake assay.
Statistics and Reproducibility
Results are expressed as mean±SEM. Comparisons between two groups were done by two-
sided Student’s t test unless otherwise noted, and analysis of variance (ANOVA) with 
Dunnett’s post-hoc testing was performed to compare 3 or more groups. A p value <0.05 
was considered statistically significant. When representative findings are presented, similar 
results were obtained at least three times. Observations in cell culture were confirmed in 
three independent experiments.
Extended Data
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Extended Data Figure 1. Establishment of mice lacking endothelial SR-B1 or PDZK1.
a,j, Schematics of the gene-targeting strategies to generate floxed alleles of Scarb1 (a) and 
PDZK1 (j) to create SR-B1fl/fl and PDZK1fl/fl mice. In SR-B1fl, exon 2 was floxed, and in 
PDZK1fl, exons 2 and 3 were floxed. The recombined alleles following Cre recombinase 
introduction are also shown. b,k, Using primers depicted in a and j, PCR-based genotyping 
was performed on aortas with versus without intact endothelial cells (EC). Aortas were 
obtained from floxed mice, and mice with Scarb1 or PDZK1 deleted selectively from EC 
(SR-B1ΔEC or PDZK1ΔEC). In genotyping evaluating Scarb1 excision (b), additional 
samples were obtained from SR-B1fl/fl mice expressing Cre recombinase globally (gCre). In 
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genotyping evaluating PDZK1 excision (k), lung samples were also studied. c,l, Quantitative 
real-time PCR analysis of SR-B1 (c) or PDZK1 expression (l) in primary aortic EC (n=6) 
and bone marrow-derived myeloid lineage cells (n=5). d,e,f, SR-B1 protein abundance (d,e, 
n=4) and ALK1 transcript levels (f, n=4) were evaluated in aortic endothelial cells from SR-
B1fl/fl and SR-B1ΔEC mice; summary data for SR-B1 protein are in e. The uncropped 
versions of all immunoblots shown are provided in Supplementary Figure 1. g,m, 
Immunoblotting of SR-B1 (g) or PDZK1 protein (m) abundance in liver. h,n, Plasma 
cholesterol levels. For SR-B1 studies, n=4,3,9 and 10 mice, respectively, for PDZK1 studies, 
n=4, 3, 6 and 6 mice, respectively. i,o, Representative lipoprotein profiles. Data are mean
±SEM; in c, e, and I, P values by two-sided Student’s t test are shown, and in h and n, P 
values by ANOVA with Dunnett’s post hoc testing are shown.
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Extended Data Figure 2. Atherosclerosis is promoted by endothelial SR-B1 but not by 
endothelial PDZK1, and neither endothelial SR-B1 nor PDZK1 affect circulating lipids.
Findings are shown for SR-B1 in mixed background females (a-g) and in C57BL/6 males 
(h-n), and for PDZK1 in C57BL6 males (o-u). Representative in situ aortic arch images of 
atherosclerotic plaque (yellow arrows) are in a, h and o, representative images for lipid-
stained lesions in en face aortas are in b, i and p, and representative images for lipid/
hematoxylin-stained aortic root sections (lesions outlined by yellow dashed line, 
magnification 40X) are in d, k and r. Lesion area quantitation in en face aortas (percent total 
surface area) are in c (n=13 and 14, respectively), j (n=10 and 9, respectively) and q (n=14/
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group), and quantitation in aortic root sections are in e (n=9/group), l (n= 10 and 9, 
respectively) and s (n=10 and 11, respectively). Plasma total cholesterol (TC), triglyceride 
(TG), and HDL cholesterol (HDL-c) are in f (n=12/group for TC and TG, and 10/group for 
HDL-c), m (n=16 and 9, respectively for TC and TG, and n=10 and 9, respectively for HDL-
c), and t (n=14/group for TC and TG, and 10/group for HDL-c); findings for SR-B1fl/fl, SR-
B1ΔEC and PDZK1ΔEC are shown in blue, red and orange, respectively. Representative 
lipoprotein profiles are in g, n and u. Data are mean±SEM. In c, e, j and l, P values by two-
sided Student’s t test are shown.
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Extended Data Figure 3. Endothelial SR-B1 promotes atherosclerosis in LDLR null mice by 
driving LDL entry into the artery wall.
a, Representative in situ aortic arch images of atherosclerotic plaque (yellow arrows) in male 
LDLR−/−;SR-B1fl/fl and LDLR−/−;SR-B1ΔEC mice. b, Representative lipid-stained en face 
images of aortas. c) Quantitation of lesion areas in en face aortas (percent of total surface 
area); n=10 and 8, respectively. d, Representative lipid/hematoxylin-stained aortic root 
sections (lesions outlined by yellow dashed line, magnification 40X). e, Quantitation of 
lesion areas in aortic root sections; n=10 and 8, respectively. f-h, Plasma total cholesterol (f), 
triglyceride (g), and HDL cholesterol (h), n=10 and 8, respectively. i, Representative 
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lipoprotein profiles. j,k, Aorta dil-nLDL uptake. Human apolipoprotein B abundance (j) or 
Dil fluorescence intensity (k) was evaluated in aorta homogenates 4h following IV DiI-
nLDL injection. Left panel in j displays a representative immunoblot with 3 samples per 
group, and in j and k, n= 5/group. l,m, Aorta dil-labeled mouse LDL (l) or mouse 
VLDL/IDL (m) uptake in LDLR−/−;SR-B1fl/fl and LDLR−/−;SR-B1ΔEC mice (n=4 and 5, 
respectively). Data are mean±SEM, P values by two-sided Student’s t test are shown.
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Extended Data Figure 4. Endothelial SR-B1 and hepatocyte SR-B1 have opposing impact on 
atherosclerosis.
Using AAV8-PCSK9, hypercholesterolemia was induced in male SR-B1fl/fl mice, and in SR-
B1ΔEC or SR-B1ΔHEP mice lacking SR-B1 selectively in endothelial cells or hepatocytes, 
respectively. Findings in SR-B1fl/fl versus SR-B1ΔEC are in a-l, and findings in SR-B1fl/fl 
versus SR-B1ΔHEP are in m-v. a, Representative in situ aortic arch images of atherosclerotic 
plaque (yellow arrows) in SR-B1fl/fl and SR-B1ΔEC mice. b, Representative lipid-stained en 
face images of aortas. c) Quantitation of lesion areas in en face aortas (percent of total 
surface area); n=12 and 10, respectively. d, Representative lipid/hematoxylin-stained aortic 
Huang et al. Page 21
Nature. Author manuscript; available in PMC 2019 October 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
root sections (lesions outlined by yellow dashed line, magnification 40X). e, Quantitation of 
lesion areas in aortic root sections; n=10 and 9, respectively. f-h, Plasma total cholesterol (f), 
triglyceride (g), and HDL cholesterol (h), n=12 and 11, respectively. i, Representative 
lipoprotein profiles. j,k, Aorta dil-nLDL uptake. Human apolipoprotein B abundance (j) or 
Dil fluorescence intensity (k) was evaluated in aorta homogenates 4h following IV injection 
(n=6 and 5, respectively). Left panel in j displays a representative immunoblot with 3 
samples per group. l, LDLR abundance in livers of control mice and SR-B1fl/fl and SR-
B1ΔEC mice administered AAV-PCSK9. Immunoblot depicts protein abundance for 2 
samples per group. m, Survival curves for SR-B1fl/fl and SR-B1ΔHEP mice, n=5 and 4, 
respectively. n, Representative lipid-stained en face images of aortas. o, Quantitation of 
lesion areas in en face aortas. Aortas and plasma were only available from two SR-B1ΔHEP 
mice. p, Longitudinal sections of SR-B1fl/fl and SR-B1ΔHEP hearts stained with H&E or 
trichrome (healthy myocardium, red/brown; fibrotic tissue, blue; yellow asterisks and arrows 
indicate areas of severe fibrosis). Images shown mirror those obtained in all 3 hearts per 
group that underwent histological analysis. q. Coronary arteries of SR-B1fl/fl and SR-
B1ΔHEP mice stained with H&E or trichrome, and coronary artery of SR-B1ΔHEP mouse 
stained with anti-CD68 to detect macrophages. r-t, Plasma total cholesterol (TC), 
triglyceride (TG), and HDL cholesterol (HCL-c). u, Representative lipoprotein profiles. v, 
Immunoblotting of SR-B1 abundance in liver, showing findings for 2 samples per group. 
Data are mean±SEM, P values by two-sided Student’s t test are shown.
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Extended Data Figure 5. Endothelial SR-B1 does not influence vascular inflammation.
a, Quantitative real-time PCR was performed to compare CD68 transcript levels in aortas 
from apoE−/−;SR-B1fl/fl and apoE−/−;SR-B1ΔEC male mice, n=8/group. b-i, mRNA 
abundance was also evaluated for the following genes, using HPRT1 as a housekeeping gene 
and normalizing expression to CD68 levels: E-selectin (b), P-selectin (c), VCAM-1 (d), 
ICAM-1 (e), TGFβ (f), TNFα (g), IL-6 (h), and IL-10 (i), with n=8/group. j, Representative 
still images of leukocyte-endothelial cell adhesion evaluated by intravital microscopy in the 
mesenteric microcirculation of apoE−/−;SR-B1fl/fl and apoE−/−;SR-B1ΔEC male mice 
administered vehicle (n=10 and 11, respectively) or TNFα (n=5 and 6, respectively). k, 
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Summary data for leukocyte velocity in four study groups in j. l, Gating strategy for 
evaluation of CD45+, F4/80+ cell number and DiI-LDL uptake in the aorta. Following 
digestion of the aorta, all cells were first gated in FSC/SSC according to cell size and 
granularity. The resulting population was gated according to cell viability using DAPI. 
DAPI- live cells were gated for positivity for CD45, and CD45+ cells were then gated for 
positivity for F4/80 and the DiI label. Data are mean±SEM; in k, P values by ANOVA with 
Dunnett’s post-hoc test are shown.
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Extended Data Figure 6. Endothelial SR-B1 drives both nLDL and oxLDL delivery into the 
artery wall.
a, Three-dimensional depiction of Dil-oxLDL localization determined by confocal 
fluorescence microscopy of the luminal surface of the ascending aorta of apoE−/−;SR-B1fl/fl 
and apoE−/−;SR-B1ΔEC mice. Lumen is on the left. DiI is shown in red and Hoechst staining 
of nuclei is shown in blue. b, Representative cumulative images of the X-Y plane parallel to 
the luminal surface. c, Summation of dil-oxLDL signal in the superficial ascending aorta. 
Two areas encompassing at least 100 cells were counted per mouse in 3 mice per group for 
total n=6/genotype group. d,e, Aorta dil-oxLDL uptake. Human apolipoprotein B abundance 
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(d) or Dil fluorescence intensity (e) was evaluated in aorta homogenates 4h following IV 
DiI-oxLDL injection; n=8/group. f,g, Using same approaches as in d and e, aorta dil-oxLDL 
uptake was evaluated in apoE−/− mice treated with control Ab or SR-B1 blocking antibody 
given IP prior to IV injection of diI-oxLDL (n=6 and 7, respectively). h, Quantification of 
CD45+, F4/80+ macrophages in the aorta (n=6/group). Results are expressed relative to 
abundance in apoE−/−;SR-B1fl/fl control mice. i, Dil-oxLDL distribution in CD45+, F4/80+ 
macrophages in the aorta, n=6/group. j,k, Aorta dil-nLDL uptake. Human apolipoprotein B 
abundance (j) or Dil fluorescence intensity (k) was evaluated in aorta homogenates 4h 
following IV DiI-nLDL injection; n=7 and 8, respectively. l,m, Using same approaches as in 
j and k, aorta dil-nLDL uptake was evaluated in apoE−/− mice treated with control Ab or SR-
B1 blocking antibody given IP prior to IV injection of diI-nLDL (n=5/group). Left panel in 
d, f, j and l displays a representative immunoblot with 3 samples per group; Data are mean
±SEM, P values by two-sided Student’s t test are shown. See also Videos 1,2.
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Extended Data Figure 7. Low-power electron micrograph images of LDL-gold and immunogold-
labeled SR-B1 in aortic endothelial cells in vivo.
Following intravascular administration in wild-type mice, gold-labeled LDL particles and 
SR-B1 were localized in aortic endothelial cells by electron microscopy. a and b display 
images for two different endothelial cells, each bordered by the lumen and elastic lamina. 
Shown are the locations of the high-power fields provided in Figure 1n, with LDL-gold 
(large particles) highlighted by yellow arrows and immunogold-labeled SR-B1 (small 
particles) highlighted by red arrows.
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Extended Data Figure 8. SR-B1 governs endothelial cell LDL transcytosis independent of effects 
on caveolae function.
a, Dil-nLDL and diI-oxLDL uptake in endothelial cells after RNAi knockdown of SR-B1 or 
PDZK1. In left panel, diI-oxLDL visualization is shown in red, and DAPI-stained nuclei are 
in blue. N=6/group. b,c, Dil-nLDL and dil-oxLDL uptake (b) and transcytosis (c) in cells 
treated with control IgG or SR-B1 blocking antibody or BLT1. N=6/group. d, Dil-nLDL and 
diI-oxLDL transcytosis in endothelial cells after RNAi knockdown of SR-B1. N=3/group. 
e,f, NOS activation by VEGF (100ng/ml) or HDL (20ug/ml) with or without RNAi 
knockdown of SR-B1 (e, n=10/group) or caveolae disruption by methyl-β-cyclodextrin 
Huang et al. Page 28
Nature. Author manuscript; available in PMC 2019 October 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
treatment (f, 10mM for 60min, n=8/group). g, Abundance of target protein following RNAi 
knockdown of SR-B1, PDZK1, LDLR or CD36 in HAEC. Findings for 3 samples per 
condition are shown. In all studies SR-B1, LDLR and CD36 expression were evaluated. h,i, 
DiI-nLDL and diI-oxLDL uptake in cells depleted of LDLR by RNAi (h, n=12 for nLDL 
and 13 for oxLDL) or treated with control versus LDLR blocking antibody (i, n=6/group). j, 
DiI-nLDL and diI-oxLDL transcytosis in cells treated with control versus LDLR blocking 
antibody. N=6 for nLDL and 3 for oxLDL. k,l, DiI-nLDL and diI-oxLDL uptake in cells 
depleted of CD36 by RNAi (k, n=6/group) or treated with control versus CD36 blocking 
antibody (l, n=9 and 12 for nLDL and 6 for oxLDL). m, DiI-nLDL and diI-oxLDL 
transcytosis in cells treated with control versus CD36 blocking antibody. N=6/group. Data 
are mean±SEM, P values by two-sided Student’s t test (a-c) or by ANOVA with Dunnett’s 
post-hoc test (d-f, h-I, k-l) are shown.
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Extended Data Figure 9. Roles of SR-B1, ALK1 and DOCK4 in endothelial cell LDL 
transcytosis.
a, Abundance of SR-B1, LDLR, and CD36 protein following RNAi knockdown of SR-B1, 
or following reconstitution of wild-type SR-B1 expression in cells depleted of endogenous 
receptor. Caveolin-1 (Cav1) expression was also evaluated. Findings for 2 samples per 
condition are shown. b, ALK1 transcript levels in cells manipulated as in a. N=4/group. c, 
Abundance of SR-B1, LDLR, and CD36 protein following RNAi knockdown of ALK1, SR-
B1, or ALK1 and SR-B1. Findings for 2 samples per condition are shown. d, ALK1 
transcript levels in cells manipulated as in c. N=4/group. e, SMAD1/5 phosphorylation in 
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response to BMP9 (10ng/ml, for 0–120 min) following RNAi knockdown of SR-B1 or 
ALK1. Abundance of SMAD1/5 Ser463/465 phosphorylation and total SMAD1 were 
evaluated by immunoblotting. f, DiI-nLDL transcytosis following RNAi knockdown of 
ALK1, SR-B1, or ALK1 and SR-B1. N=9/group. g,h, nLDL uptake was evaluated using 
125I-nLDL in the absence or presence of 50-fold excess unlabeled nLDL (g), and h, 
following RNAi knockdown of SR-B1 or DOCK4, or reconstitution of wild-type SR-B1 
expression in cells depleted of endogenous receptor. N=8/group. i,j, nLDL transcytosis was 
evaluated using 125I-nLDL in the absence versus presence of 50-fold excess unlabeled nLDL 
(i), and j, following manipulation of SR-B1 or DOCK4 expression as in h. N=3/group. k,l, 
nLDL transcytosis was evaluated using total internal reflection fluorescence (TIRF) 
microscopy in cells treated with Dyngo4A (k, 30uM) and l, in cells following RNAi 
knockdown of SR-B1 or DOCK4. N=6/group. m, Rac1 activation in response to oxLDL was 
determined in cells expressing GFP control versus dominant-negative Rac1, and in untreated 
cells versus cells incubated with the Rac1 inhibitor NSC23766. Data are mean±SEM, P 
values by ANOVA with Dunnett’s posthoc test (d, f, h, j, l) or by two-sided Student’s t test 
(g, i, k) are shown.
Huang et al. Page 31
Nature. Author manuscript; available in PMC 2019 October 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 10. Lentiviral reconstitution of wild-type and mutant SR-B1 expression in human 
endothelial cells.
a-c, Studies of reconstituted wild-type SR-B1 (WT), extracellular point mutant SR-B1, or 
SR-B1-Q445A. The extracellular point mutants were: SR-B1-M159E, T165E, F171A, 
T175A, and E178A. Whole cell lysate abundance (a), cell surface abundance (b; except for 
Q445A, which was previously evaluated), and nLDL and oxLDL binding (c) were evaluated. 
d-f, Studies of reconstituted WT or C-terminal cytoplasmic tail deletion mutant SR-B1. The 
mutants were: SR-B1-ΔC15 (Δ495–509), ΔC23 (Δ487–509) and ΔC30 (Δ480–509). Whole 
cell lysate abundance (d), cell surface abundance (e), and nLDL and oxLDL binding (f) 
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were evaluated. g, Upper Panel: Sequence alignment of amino acids in the C-terminal 
cytoplasmic tail of SR-B1 homologs (residues 487–494) from human (Homo sapien, Hs, 
Q8WTVO, Swiss-Prot), mouse (Mus musculus, Mm, Q61009, Swiss- Prot), rat (Rattus 
norvegius, Rr, P97943, Swiss-Prot), bovine (Bos Taurus, Bt, O18824, Swiss-Prot), pig (Sus 
scrofa, Ss, Q8SQC1, Swiss-Prot), and Chinese hamster (Cricetulus griseus, Cg, Q60417, 
Swiss-Prot). Fully conserved residues are shown in bold. Lower Panel: Comparison of 
human SR-B1 residues 487–494 and entire human CD36 C-terminal cytoplasmic tail. 
Residues of SR-B1 not shared with CD36 are shown in bold. h-j, Studies of reconstituted 
WT or C-terminal cytoplasmic tail substitution mutant SR-B1. The mutants were: SR-B1-
IQAY, SESL, Y490A, Q488A, S491A, E492A, S493A, and L494A. Whole cell lysate 
abundance (h), cell surface abundance (i), and nLDL and oxLDL binding (j) were evaluated. 
k-m, nLDL binding (k), uptake (l) and transcytosis studies (m) were performed with the 
various mutants shown at an nLDL concentration of 100ug/ml. n, Whole cell lysate 
abundance of CD36 and LDLR was evaluated following reconstitution with the SR-B1 
mutants tested in k-m. Data are mean±SEM. For cell surface abundance by flow cytometry, 
n=3 or 4. For LDL binding, n=4 or 8. For LDL transcytosis, n=3. In c, k-m, P values for 
comparison with WT by two-sided Student’s t test are shown.
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Figure 1. Endothelial SR-B1 promotes atherosclerosis by driving LDL delivery into the artery 
wall and uptake by artery wall macrophages.
a, Representative in situ aortic arch images of atherosclerotic plaque (yellow arrows) in male 
apoE−/−;SR-B1fl/fl and apoE−/−;SR-B1ΔEC mice. b, Representative lipid-stained en face 
images of aortas. c, Quantitation of lesion areas in en face aortas (percent of total surface 
area); n=9 and 16, respectively. d, Representative lipid/hematoxylin-stained aortic root 
sections (lesions outlined by yellow dashed line, magnification 40X), e, Quantitation of 
lesion areas in aortic root sections; n=9 and 16, respectively. f-h, Plasma total cholesterol (f) 
and triglyceride (g, n=9 and 14, respectively), and HDL cholesterol (h, n=7 and 9, 
respectively). i, Representative lipoprotein profiles. j, Three-dimensional depiction of Dil-
nLDL localization determined by confocal fluorescence microscopy of the luminal surface 
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of the ascending aorta. Lumen is on the left. DiI is shown in red and Hoechst staining of 
nuclei is shown in blue. k, Representative cumulative images of the X-Y plane parallel to the 
luminal surface. l, Summation of dil-nLDL signal in the superficial ascending aorta. Four 
areas encompassing at least 100 cells were counted per mouse in 3 mice per group for total 
n=12/genotype group. m, Evaluation of aorta endothelial permeability by quantification of 
Evans blue dye incorporation (n=7 and 8, respectively). n, Gold-labeled LDL (large 
particles, yellow arrows) and immunogold-labeled SR-B1 (small particles, red arrows) are 
colocalized in endothelial cell intracellular vesicles in vivo. Representative images from two 
different endothelial cells are shown. o, Quantification of CD45+, F4/80+ macrophages in 
the aorta (n=4 and 5, respectively). Results are expressed relative to abundance in apoE
−/−;SR-B1fl/fl control mice. p, Dil-nLDL distribution in CD45+, F4/80+ macrophages in the 
aorta; n=4 and 5, respectively. Data are mean±SEM, P values by two-sided Student’s t test 
are shown. See also Extended Data Figs. 1a–i, 2–4, 6 and 7.
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Figure 2. SR-B1 mediation of endothelial cell LDL uptake and transcytosis requires LDL 
binding to SR-B1 and an 8 amino acid cytoplasmic domain.
a, Schematic of mutant forms of SR-B1 studied by reconstitution in HAEC. b,c, nLDL and 
oxLDL uptake (b, n=8 for nLDL and 6 for oxLDL) and transcytosis (c, n=3) by wild-type 
(WT) SR-B1 versus LDL binding point mutants or SR-BI-Q445A. d,e, nLDL and oxLDL 
uptake (d, n=8 for nLDL and 6 for oxLDL) and transcytosis (e, n=3) by WT SR-B1 versus 
C-terminal cytoplasmic tail deletion mutants. f,g, nLDL and oxLDL uptake (f, n=6 or 8) and 
transcytosis (g, n=3) by WT SR-B1 versus C-terminal cytoplasmic tail substitution mutants. 
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Data are mean±SEM, P values by ANOVA with Dunnett’s post-hoc testing are shown. See 
also Extended Data Fig. 10.
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Figure 3. SR-B1 dynamically interacts with DOCK4 in endothelial cells, and their expression is 
increased in atherosclerosis-prone regions of mouse aorta prior to lesion formation, and in 
human atherosclerotic versus normal arteries.
a, HAEC expressing His-tagged wild-type SR-B1 or SR-B1-ΔC23 were treated with vehicle 
or oxLDL, DOCK4 was immunoprecipitated (IP), and immunoblotting was done for 
DOCK4 and SR-B1. First IP lane shows IP done with unrelated IgG. b, Same experiment 
was performed in HAEC expressing His-tagged wild-type SR-B1, SR-B1-IQAY or SR-B1-
SESL. c, HAEC reconstituted with His-tagged wild-type SR-B1 were treated with nLDL or 
oxLDL, DOCK4 was IP’d and immunoblotting was done for DOCK4 and SR-B1. Summary 
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data are for n=4 per group; P values by ANOVA with Dunnett’s post-hoc testing are shown. 
d, SR-B1 and DOCK4 expression were evaluated in intact versus endothelium-denuded 
mouse aorta by Q-RT-PCR, n=3 arteries per group. e, Left panel: In situ image of aortic arch 
from a wild-type, atherosclerosis-free mouse, depicting regions of greater curvature (blue 
hashed line) and lesser curvature (red hashed line) sampled for experiment in f. Right panel: 
In situ image of aortic arch from apoE−/− mouse with atherosclerotic lesions absent in 
greater curvature and present in lesser curvature. f, SR-B1 and DOCK4 expression were 
evaluated in greater and lesser curvature samples by Q-RT-PCR, n=4 arteries per group. g-l, 
Employing three separate patient cohorts and independent strategies for analyses, SR-B1 (g-
i) and DOCK4 expression (j-l) were compared in human atherosclerotic versus control 
arteries. Cohorts I, II and III contained n=4 and 207, 40 and 40, and 32 and 32, respectively. 
Data are mean±SEM; in d and f, P values by two-sided Student’s t test are shown; in g-l, 
data are presented as box-and-whisker plots, with the central lines denoting medians, edges 
of the box representing upper and lower quartiles, and whiskers showing minimum and 
maximum values after excluding outliers outside 1.5 times the interquartile range.
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Figure 4. DOCK4 mediates endothelial cell LDL uptake and transcytosis by internalizing SR-B1 
and coupling the receptor to Rac1.
a,b, The internalization of biotinylated SR-B1 and transferrin receptor (TR) was evaluated 
following warming from 4°C to 37°C in nLDL- (a) or oxLDL-treated (b) endothelial cells 
with normal versus decreased DOCK4 expression. In a-b, n=3/condition and P values by 
two-sided Student’s t test are shown. c,d, DiI-nLDL binding to endothelial cells was 
evaluated in the presence versus absence of DOCK4 in cells expressing versus deficient in 
SR-B1 (c, n=6) or LDLR and CD36 (d, n=4). In c-d, P values by ANOVA with Dunnett’s 
post-hoc testing are shown. e,f, nLDL and oxLDL uptake (e, n=3 for nLDL and n=8 for 
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oxLDL) and transcytosis (f, n=3) in cells with normal versus decreased DOCK4 expression. 
g, HDL transcytosis in cells with normal versus decreased expression of SR-B1 or DOCK4, 
n=3. h,i, Rac1 is activated by nLDL (h) or oxLDL (i) via SR-B1 and DOCK4 in endothelial 
cells. Left panel: Cells were treated with LDL for 0–60 min and Rac1 activity was 
determined. Right panel: Rac1 activation in response to LDL was evaluated in cells 
expressing or lacking SR-B1 or DOCK4. j, Rac1 activation is required for SR-B1-mediated 
nLDL or oxLDL uptake in endothelial cells. Cells were transfected with GFP control versus 
dominant-negative Rac1, or treated with vehicle versus the Rac1 inhibitor NSC23766; n=8. 
Data are mean±SEM, in e-g and j, P values by two-sided Student’s t test are shown. See also 
Extended Data Fig. 9g–m. k, Summary scheme: SR-B1 transports LDL across the 
endothelial cell monolayer and thereby governs the accumulation of LDL by arterial wall 
macrophages, which become foam cells and atherosclerotic lesion development ensues. The 
transcytosis of LDL across the endothelial cell monolayer requires an 8 amino acid 
cytoplasmic domain of SR-B1, which recruits DOCK4, and DOCK4 promotes SR-B1 
internalization and LDL transport by coupling LDL binding to SR-B1 with Rac1 activation.
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